Refractory Subcutaneous Sweet Syndrome Treated With Adalimumab.
Publication
, Journal Article
Agarwal, A; Barrow, W; Selim, MA; Nicholas, MW
Published in: JAMA Dermatol
July 1, 2016
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
JAMA Dermatol
DOI
EISSN
2168-6084
Publication Date
July 1, 2016
Volume
152
Issue
7
Start / End Page
842 / 844
Location
United States
Related Subject Headings
- Treatment Outcome
- Sweet Syndrome
- Subcutaneous Tissue
- Recurrence
- Middle Aged
- Male
- Immunohistochemistry
- Humans
- Follow-Up Studies
- Drug Administration Schedule
Citation
APA
Chicago
ICMJE
MLA
NLM
Agarwal, A., Barrow, W., Selim, M. A., & Nicholas, M. W. (2016). Refractory Subcutaneous Sweet Syndrome Treated With Adalimumab. JAMA Dermatol, 152(7), 842–844. https://doi.org/10.1001/jamadermatol.2016.0503
Agarwal, Ashwin, Willis Barrow, M Angelica Selim, and Matilda W. Nicholas. “Refractory Subcutaneous Sweet Syndrome Treated With Adalimumab.” JAMA Dermatol 152, no. 7 (July 1, 2016): 842–44. https://doi.org/10.1001/jamadermatol.2016.0503.
Agarwal A, Barrow W, Selim MA, Nicholas MW. Refractory Subcutaneous Sweet Syndrome Treated With Adalimumab. JAMA Dermatol. 2016 Jul 1;152(7):842–4.
Agarwal, Ashwin, et al. “Refractory Subcutaneous Sweet Syndrome Treated With Adalimumab.” JAMA Dermatol, vol. 152, no. 7, July 2016, pp. 842–44. Pubmed, doi:10.1001/jamadermatol.2016.0503.
Agarwal A, Barrow W, Selim MA, Nicholas MW. Refractory Subcutaneous Sweet Syndrome Treated With Adalimumab. JAMA Dermatol. 2016 Jul 1;152(7):842–844.
Published In
JAMA Dermatol
DOI
EISSN
2168-6084
Publication Date
July 1, 2016
Volume
152
Issue
7
Start / End Page
842 / 844
Location
United States
Related Subject Headings
- Treatment Outcome
- Sweet Syndrome
- Subcutaneous Tissue
- Recurrence
- Middle Aged
- Male
- Immunohistochemistry
- Humans
- Follow-Up Studies
- Drug Administration Schedule